title: Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.
abstract: Drug-drug interactions (DDIs) and associated toxicity from cardiovascular drugs represents a major problem for effective co-administration of cardiovascular therapeutics. A significant amount of drug toxicity from DDIs occurs because of drug interactions and multiple cardiovascular drug binding to the efflux transporter P-glycoprotein (Pgp), which is particularly problematic for cardiovascular drugs because of their relatively low therapeutic indexes. The calcium channel antagonist, verapamil and the cardiac glycoside, digoxin, exhibit DDIs with Pgp through non-competitive inhibition of digoxin transport, which leads to elevated digoxin plasma concentrations and digoxin toxicity. In the present study, verapamil-induced ATPase activation kinetics were biphasic implying at least two verapamil-binding sites on Pgp, whereas monophasic digoxin activation of Pgp-coupled ATPase kinetics suggested a single digoxin-binding site. Using intrinsic protein fluorescence and the saturation transfer double difference (STDD) NMR techniques to probe drug-Pgp interactions, verapamil was found to have little effect on digoxin-Pgp interactions at low concentrations of verapamil, which is consistent with simultaneous binding of the drugs and non-competitive inhibition. Higher concentrations of verapamil caused significant disruption of digoxin-Pgp interactions that suggested overlapping and competing drug-binding sites. These interactions correlated to drug-induced conformational changes deduced from acrylamide quenching of Pgp tryptophan fluorescence. Also, Pgp-coupled ATPase activity kinetics measured with a range of verapamil and digoxin concentrations fit well to a DDI model encompassing non-competitive and competitive inhibition of digoxin by verapamil. The results and previous transport studies were combined into a comprehensive model of verapamil-digoxin DDIs encompassing drug binding, ATP hydrolysis, transport and conformational changes.
authors.affiliation: Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA 30602, U.S.A.
authors.forename: Kaitlyn V
authors.initials: KV
authors.lastname: Ledwitch
authors.affiliation: Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA 30602, U.S.A.
authors.forename: Robert W
authors.initials: RW
authors.lastname: Barnes
authors.affiliation: Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA 30602, U.S.A. audie@uga.edu.
authors.forename: Arthur G
authors.initials: AG
authors.lastname: Roberts
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000737:chemistry* / Q000378:metabolism; D000818:Animals; D001693:Biological Transport, Active; D004077:Digoxin / Q000737:chemistry* / Q000493:pharmacokinetics; D004347:Drug Interactions; D051379:Mice; D008956:Models, Chemical; D014700:Verapamil / Q000737:chemistry* / Q000493:pharmacokinetics
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D004077:Digoxin; D014700:Verapamil
keywords: ABC transporter; NMR; cardiovascular; drug transport; fluorescence
references.citation: J Biol Chem. 2003 Oct 10;278(41):39706-10
references.pmid: 12909621
references.citation: Circulation. 1982 Jan;65(1):22-7
references.pmid: 7053285
references.citation: J Biol Chem. 2003 Jan 17;278(3):1575-8
references.pmid: 12421806
references.citation: Am J Cardiovasc Drugs. 2004;4(5):281-97
references.pmid: 15449971
references.citation: BMC Med. 2004 Apr 2;2:8
references.pmid: 15061868
references.citation: Biol Pharm Bull. 2006 Mar;29(3):560-4
references.pmid: 16508168
references.citation: J Pharmacol Exp Ther. 2002 Dec;303(3):1029-37
references.pmid: 12438524
references.citation: J Biol Chem. 2011 Nov 11;286(45):39489-96
references.pmid: 21937435
references.citation: Am J Cardiovasc Drugs. 2013 Oct;13(5):331-42
references.pmid: 23784266
references.citation: Annu Rev Pharmacol Toxicol. 1977;17:149-66
references.pmid: 326161
references.citation: Phytother Res. 2009 Jan;23(1):86-91
references.pmid: 18688789
references.citation: Methods Mol Biol. 2012;914:47-63
references.pmid: 22976022
references.citation: J Biol Chem. 1996 Feb 9;271(6):3163-71
references.pmid: 8621716
references.citation: J Biol Chem. 1995 Nov 10;270(45):26956-61
references.pmid: 7592942
references.citation: Circulation. 1999 Feb 2;99(4):472-4
references.pmid: 9927391
references.citation: J Biol Chem. 2003 Apr 18;278(16):13603-6
references.pmid: 12609990
references.citation: Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):235-8
references.pmid: 12051123
references.citation: J Biol Chem. 1999 Dec 3;274(49):34711-8
references.pmid: 10574938
references.citation: Biochem Biophys Res Commun. 2007 Aug 10;359(4):866-70
references.pmid: 17574211
references.citation: Biochemistry. 2007 Mar 20;46(11):3394-404
references.pmid: 17302433
references.citation: J Am Chem Soc. 2005 Jan 26;127(3):916-9
references.pmid: 15656629
references.citation: Life Sci. 1993;53(24):PL399-403
references.pmid: 8246676
references.citation: Biochem J. 1995 Jun 1;308 ( Pt 2):381-90
references.pmid: 7772017
references.citation: J Am Chem Soc. 2001 Jun 27;123(25):6108-17
references.pmid: 11414845
references.citation: Biochem J. 1996 Jul 15;317 ( Pt 2):515-22
references.pmid: 8713080
references.citation: Anal Biochem. 1988 Jan;168(1):1-4
references.pmid: 2834977
references.citation: Biochim Biophys Acta. 1998 Feb 2;1369(1):85-93
references.pmid: 9528676
references.citation: Nucl Med Biol. 2013 Oct;40(7):873-8
references.pmid: 23845421
references.citation: J Biol Chem. 2012 Jan 6;287(2):1112-27
references.pmid: 22086917
references.citation: J Nucl Med. 2013 Mar;54(3):437-46
references.pmid: 23359659
references.citation: Methods Enzymol. 2003;367:3-14
references.pmid: 14611054
references.citation: J Young Pharm. 2011 Oct;3(4):329-33
references.pmid: 22224041
references.citation: Biochim Biophys Acta. 1993 Feb 23;1146(1):65-72
references.pmid: 8095161
references.citation: Trends Biochem Sci. 1990 Dec;15(12):455-8
references.pmid: 2077683
references.citation: Biochemistry. 1999 Oct 19;38(42):13887-99
references.pmid: 10529234
references.citation: J Med Chem. 1993 Apr 16;36(8):1017-23
references.pmid: 8478901
references.citation: Oncologist. 2007 Aug;12(8):927-41
references.pmid: 17766652
references.citation: Eur J Biochem. 2001 Apr;268(8):2416-20
references.pmid: 11298761
references.citation: Environ Sci Technol. 2008 Feb 15;42(4):1084-90
references.pmid: 18351076
references.citation: Biochemistry. 2011 Dec 20;50(50):10804-18
references.pmid: 21992114
references.citation: J Pharmacol Exp Ther. 2000 May;293(2):376-82
references.pmid: 10773005
references.citation: Bioinformatics. 2006 Dec 15;22(24):3067-74
references.pmid: 17032683
references.citation: Pharmacol Res. 1999 Oct;40(4):301-6
references.pmid: 10527640
references.citation: Biochemistry. 1998 Nov 17;37(46):16400-9
references.pmid: 9819232
references.citation: J Pharmacol Exp Ther. 2001 Nov;299(2):620-8
references.pmid: 11602674
references.citation: Biochemistry. 2004 Apr 6;43(13):3917-28
references.pmid: 15049699
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):11-26
references.pmid: 18758752
references.citation: Cardiovasc Res. 1978 Apr;12(4):247-54
references.pmid: 657182
references.citation: N Z Med J. 1978 May 24;87(612):351-4
references.pmid: 353597
references.citation: Int J Pharm. 2005 Jan 20;288(2):349-59
references.pmid: 15620875
references.citation: PLoS One. 2011;6(8):e22577
references.pmid: 21826197
references.citation: Methods Mol Biol. 2003;227:109-28
references.pmid: 12824647
references.citation: Biochem Pharmacol. 2008 Oct 1;76(7):850-61
references.pmid: 18703021
references.citation: Eur J Biochem. 1998 Aug 15;256(1):170-8
references.pmid: 9746361
references.citation: J Biol Chem. 1999 Jun 18;274(25):17649-54
references.pmid: 10364203
references.citation: J Biol Chem. 1995 Jul 21;270(29):17159-70
references.pmid: 7615512
references.citation: Methods Enzymol. 2003;372:65-86
references.pmid: 14610807
references.citation: J Histochem Cytochem. 2002 Oct;50(10):1351-6
references.pmid: 12364568
references.citation: Aust N Z J Med. 1979 Feb;9(1):62-4
references.pmid: 36879
references.citation: Eur J Clin Pharmacol. 1982;22(2):123-7
references.pmid: 7094982
references.citation: Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):36-46
references.pmid: 23286289
references.citation: ACS Chem Biol. 2009 Feb 20;4(2):139-44
references.pmid: 19175306
references.citation: Biochemistry. 1999 May 25;38(21):6887-96
references.pmid: 10346910
references.citation: Biochim Biophys Acta. 2008 Feb;1778(2):376-91
references.pmid: 18035039
references.citation: Methods Enzymol. 2009;464:211-31
references.pmid: 19903557
references.citation: Eur J Biochem. 1998 Jan 15;251(1-2):252-61
references.pmid: 9492291
references.citation: J Am Geriatr Soc. 1986 Sep;34(9):659-62
references.pmid: 3734315
references.citation: Circulation. 1982 May;65(5):998-1003
references.pmid: 7074765
references.citation: Int J Pharm. 2003 Sep 16;263(1-2):113-22
references.pmid: 12954186
references.citation: Hematol Oncol Clin North Am. 1995 Apr;9(2):319-36
references.pmid: 7642466
references.citation: J Med Chem. 2003 Apr 24;46(9):1716-25
references.pmid: 12699389
references.citation: Biochim Biophys Acta. 1997 Aug 22;1361(2):159-68
references.pmid: 9300797
references.citation: Curr Opin Chem Biol. 2011 Aug;15(4):489-96
references.pmid: 21665521
references.citation: Reprod Toxicol. 2006 Oct;22(3):400-10
references.pmid: 16563694
references.citation: J Biol Chem. 2002 Nov 1;277(44):41303-6
references.pmid: 12226074
references.citation: J Biol Chem. 2003 Jun 6;278(23):20449-52
references.pmid: 12711602
references.citation: Biochem Biophys Res Commun. 1995 Nov 13;216(2):602-9
references.pmid: 7488154
references.citation: J Biol Chem. 1995 Mar 24;270(12):6686-90
references.pmid: 7896810
references.citation: Biophys J. 2005 Jul;89(1):418-32
references.pmid: 15834000
references.citation: Biochim Biophys Acta. 1992 Jun 11;1107(1):105-10
references.pmid: 1352129
references.citation: Drug Metab Dispos. 2005 Nov;33(11):1679-87
references.pmid: 16093365
references.citation: Biochem J. 2006 Oct 15;399(2):315-23
references.pmid: 16803457
references.citation: Biochim Biophys Acta. 1997 Aug 22;1361(2):169-76
references.pmid: 9300798
references.citation: J Pharm Sci. 1991 Jun;80(6):586-9
references.pmid: 1658296
references.citation: Biochemistry. 2000 Dec 5;39(48):14927-38
references.pmid: 11101309
references.citation: Ther Drug Monit. 2000 Feb;22(1):137-40
references.pmid: 10688277
references.citation: J Biol Chem. 1993 Nov 15;268(32):24197-202
references.pmid: 7901214
references.citation: Front Oncol. 2014 Mar 03;4:41
references.pmid: 24624364
references.citation: J Biol Chem. 2012 Aug 3;287(32):26806-16
references.pmid: 22700974
references.citation: Pharmacol Rev. 2006 Jun;58(2):244-58
references.pmid: 16714487
references.citation: Cardiovasc Res. 2004 Oct 1;64(1):32-9
references.pmid: 15364611
references.citation: Crit Pathw Cardiol. 2011 Jun;10(2):93-8
references.pmid: 21988950
references.citation: J Am Coll Cardiol. 2013 Jun 25;61(25):2495-502
references.pmid: 23563132
references.citation: Biochim Biophys Acta. 1997 Aug 22;1361(2):147-58
references.pmid: 9300796
references.citation: Eur J Biochem. 1998 Jul 15;255(2):383-90
references.pmid: 9716379
references.citation: Mol Pharm. 2005 Jul-Aug;2(4):329-40
references.pmid: 16053336
references.citation: Curr Protoc Mol Biol. 2001 May;Chapter 13:Unit13.13
references.pmid: 18265097
references.citation: J Biol Chem. 1995 Jul 7;270(27):16167-75
references.pmid: 7608182